Sam Rodriguez claims to have proposed the concept of Focused Research Organizations (FROs) for science projects that are too large for academia but not commercially viable for for-profit companies.

A paper detailing a discovery made by Edison Scientific's AI agent system, Robin, was published in the journal Nature.

AI drug discovery startups like Chai Discovery and Isomorphic primarily focus on creating novel molecules and then partnering with large pharmaceutical companies for development, rather than developing the drugs themselves.